Zimmer Biomet Holdings, Inc.
Clinical trials sponsored by Zimmer Biomet Holdings, Inc., explained in plain language.
Medical device company specializing in orthopedic implants and joint replacement.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bone cement tested for hip and knee implants Results expected Oct 2026 (estimated)
- New implant aims to strengthen shoulder tendon repair after replacement Results expected Nov 2026 (estimated)
- Researchers track shoulder implant longevity to improve future surgeries Results expected Dec 2026 (estimated)
- New shoulder implant study aims to ease severe arthritis and rotator cuff damage Results expected Dec 2026 (estimated)
- New study confirms shoulder fracture hardware holds up Results expected Dec 2026 (estimated)